Ludovic Begue

SAS Sainte-Barbe leases and manages social housing and apartment properties. Its other activities include repairs and maintenance of buildings and premises. The company is headquartered in Freyming-Merlebach, France.

MYOSIX SA develops cell-based therapeutics. The company is involved in the development of autologous cell therapy products for the treatment of cardiopathies and certain forms of myopathy in humans. MYOSIX specializes in the development of cell-based therapeutics against other pathologies like cancers. MYOSIX is also engaged in a number of R&D projects and develops a cell and tissue bank for therapeutic or R&D purposes. The company was founded by Vilquin, Marolleau, Scorsin, Eisenmann and Halioua in 2000 and is headquartered in Saint-Germain-en-Laye, France.

Sia Habitat SA leases apartment buildings. It offers broker deals for the acquisition and leasing of residential units. The company was founded on March 14, 1955 and is headquartered in Douai, France.

Société Immobilière du Département de la Réunion (SIDR) is a real estate company based in Saint-Denis, France. The French company provides social housing services to tenants in Réunion, offering accommodation offers and essential information to find a suitable place to live. SIDR also organizes events and activities to promote social inclusion and cohesions among tenants, such as sports activities, urban dance battles, and educational workshops. Additionally, the private company partners with associations to provide support and advice for carrying out small rental repair work to tenants. Jacques Durand has been the CEO of the company since 2018.

SCIC Habitat Bourgogne SA D'habitations à Loyer Modéré is a company based in Dijon, France. The French company provides social rental housing services. The company is ultimately controlled by the Government of France. The CEO of the company is Dominique Chauvet.

CDC Habitat Social SA d'Habitation à Loyer Modéré provides online rental accommodation services. The company is headquartered in Paris, France.

Adoma SA provides housing services. The company was founded in 1956 and is headquartered in Paris, France.

Gauthier SA provides construction services. Since the founding in 1840 a company of plastering - staff - painting, the 5 stars that today characterize the society Gauthier, his experience and his men, was able to adapt to new markets by offering its partners to modern and efficient techniques. Accustomed to a demanding customer attached to the quality of all time, the company remains the regional specialist of careful finishing.

Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France.

Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France.

Pervasis Therapeutics, Inc. is a clinical stage company developing a broad portfolio of biologically active therapeutics. The company was founded by Robert S. Langer Jr. and Helen Marie Nugent in 2004 and is headquartered in Waltham, MA.

Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA

Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

SPL Delta 3 provides engineering and technical study services. The company is based in Lille, France. The French company is ultimately controlled by the Government of France. The CEO of the company is Emmanuel Favreuille.